Entity: all
News about Novartis
ShareAnalyse the news about Novartis from multiple sources, get visualizations or extract the entire dataset.
Related dashboards:
- Novartis (organization)
Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns
Novartis agrees $3bn deal to buy heart drug biotech from Blackstone
Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
Novartis Lifts Sales Outlook on Key Drugs, Pipeline Portfolio
Siemens Healthineers boosts cancer imaging with EUR200mn Novartis deal
Stocks making the biggest premarket moves: General Motors, GE Aerospace, Novartis, JetBlue and more
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
Novartis wants to buy a German cancer drugmaker as it stops recruiting for its own trials
Novartis, Roche's Food Allergies Treatment Xolair Gets FDA Approval
Novartis in the lead to acquire cancer drug developer MorphoSys, sources say
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H
Dataset
Extract all news on this scope:
Analysis
See the trend on this scope:
Evolution through time
Sources analysis:
Distribution of sources in the news
Sections analysis:
Distribution of sections in the news
Current sentiment polarity: slightly positive with a score of 0.49
| positive | 62% | |
| neutral | 25% | |
| negative | 12% |
Sentiment polarity through time
